References
- World Health Organization The Lactation amenorrhea method (LAM) for postpartum contraception. Geneva: World Health Organization; 2006.
- Coeytaux F, Wells ES, Westley E. Emergency contraception: have we come full circle? Contraception. 2009;80(1):1–3.
- Shaaban OM, Fathalla MM, Shahin AY, et al. Emergency contraception in the context of marriage in Upper Egypt. Int J Gynecol Obstet. 2011;112(3):195–199.
- Daniels K, Jones J, Abma J. 2006–2010. Use of emergency contraception among women egged. Data Brief. 2013;112:15.
- Weimer JP. The economic benefits of breastfeeding: a review and analysis. Food assistance and nutritional. Research Report. No. 13. 2009.
- Radwan H, Mussaiger AO, Hachem F. Breast-feeding and lactational amenorrhea in the United Arab Emirates. J Pediatr Nurs. 2009;24(1):62–68.
- Lopez LM, Grey TW, Stuebe AM, et al. Combined hormonal versus non-hormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev. 2015;20(3):CD003988.
- King J. Contraception and lactation. J Midwif Womens Health. 2007;52(6):614–620.
- Kliegman RM, Behrman RE, Jenson HB, et al. Nelson textbook of pediatrics. 19th ed. Philadelphia, PA: Elsevier Saunders; 2011; Chap 108.
- Shaaban OM, Abbas AM, Mahmoud HR, et al. Counseling and in-advance provision of levonorgestrel emergency contraceptive pills decrease the rate of unplanned pregnancy during breastfeeding: a randomized controlled trial. J Matern Fetal Neonatal Med. 2017 [Nov 21]; [6 p.]. DOI:10.1080/14767058.2017.1403580
- Glascoe FP, Foster EM, Wolraich ML. An Economic analysis of developmental detection methods. Pediatrics. 1997;99(6):830–837.
- Phillips SJ, Tepper NK, Kapp N, et al. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2016;94(3):226–252.
- Speroff L, Mishell DR. The postpartum visit: it’s time for a change in order to optimally initiate contraception. Contraception. 2008;78(2):90–98.
- World Health Organization Selected practice recommendations for contraceptive use. Geneva, Switzerland: World Health Organization; 2002.
- WHO. Medical eligibility criteria for contraceptive use [Internet]. [cited 2017 Oct 5]. Available from: http://who.int/reproductive health/publications/family_planning/MEC-5/en/
- Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103.
- Faculty of Sexual and Reproductive Healthcare [Internet]. UK medical eligibility criteria for contraceptive use 2016. Clinical Effectiveness Unit; 2016 [cited 2017 Oct 5]. Available from: www.fsrh.org.uk
- US medical eligibility criteria (USMEC) for contraceptive use [Internet]. 2016 [cited 2017 Oct 7]. Available from: www.cdc.gov
- World Health Organization Task Force for Epidemiological Research on Reproductive Health. Special Programme of Research, Development and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation. II. Infant Development. Contraception. 1994;50:55–68.
- Bassol S, Nava-Hernandez MP, Hernandez-Morales C, et al. Effects of levonorgestrel implant upon TSH and LH levels in male infants during lactation. Int J Gynecol Obstet. 2002;76(3):273–277.
- Schiappacasse V, Díaz S, Zepeda A, et al. Health and growth of infants breastfed by Norplant contraceptive implant users: a six-year follow-up study. Contraception. 2002;66(1):57–65.
- Gainer E, Massai R, Lillo S, et al. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception. Hum Reprod. 2007;22(6):1578–1584.
- Hale TM. Medications and mothers milk. 14th ed. Amarillo, TX: Pharmasoft Publishing; 2010. p. 597–600.
- Polakow-Farkash S, Gilad O, Merlob P, et al. Levonorgestrel used for emergency contraception during lactation-A prospective observational cohort study on maternal and infant safety. J Matern Fetal Neonatal Med. 2013;26(3):219–221.